article thumbnail

How retailers and “payviders” are disrupting U.S. healthcare in 2024

Clarivate

Strategy #1: innovate and create Amazon founder Jeff Bezos has said that overnight success takes about 10 years — and that ramp-up period may be what’s playing out for the ecommerce giant in healthcare. billion, following an earlier failed healthcare venture with Berkshire Hathaway and JPMorgan Chase.

Retail 52
article thumbnail

Access solutions: the missing link that prevents biopharma innovation from reaching patients

pharmaphorum

However, most models are based on an old-fashioned and expensive call centre-based approach that fails to meet the needs of patients and healthcare providers (HCPs) as consumers. Yet, the healthcare experience is antiquated.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Challenging State Abortion Bans in Light of FDA’s Rule Change on the Sale of Abortion Pills

MedCity News

The current legal landscape makes access to medication abortion crucial in protecting as much access to reproductive healthcare as possible and in protecting healthcare providers’ abilities to do their jobs without fear of prosecution.

article thumbnail

U.S. market access landscape: A push for control is erasing the boundary between payers and providers in U.S. healthcare

Clarivate

healthcare payers and providers are consolidating at a dizzying clip as they seek to gain market share, increase access to care and secure clinical control to improve health outcomes. CVS’ bid for Oak Street is in keeping with nearly two decades of evolution toward becoming an integrated payer and provider.

article thumbnail

AmerisourceBergen introduces CGT integration hub

Pharmaceutical Technology

Global healthcare company AmerisourceBergen has launched a cell and gene therapy (CGT) integration hub. The new system can be integrated with biopharma or provider-facing platforms to enable the exchange of information in real time.

article thumbnail

Navigating the rapidly changing oncology treatment landscape: how digital tools can help

Impetus Digital

Emerging biopharma companies are responsible for over 70% of these products (up 20 percentage points from 2017) while Big Pharma has seen a declining share of the oncology pipeline, at only around 20% of products currently under development (down 15 percentage points from 2017).

article thumbnail

Fireside Chat with Dr. Ittai Dayan, Co-founder & CEO at Rhino Health

Impetus Digital

Ittai Dayan , Co-founder & CEO of Rhino Health , will join Natalie Yeadon , Co-founder & CEO of Impetus Digital , to share how his company is transforming the way healthcare AI solutions are created, adopted and measured. About Impetus Digital. Book a Consultative Demo.